We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Covis Pharma Initiates Phase 3 Trial of Alvesco Asthma Inhaler for COVID-19
Covis Pharma Initiates Phase 3 Trial of Alvesco Asthma Inhaler for COVID-19
Covis Pharma has begun a phase 3 trial of its approved asthma drug Alvesco (ciclesonide) in non-hospitalized COVID-19 patients ages 12 years and older.